Mycophenolate mofetil in the treatment of Chinese patients with lupus nephritis
Author:
Funder
Shanghai Roche Pharmaceuticals Ltd.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference39 articles.
1. Changes in the spectrum of kidney diseases: an analysis of 40,759 biopsy-proven cases from 2003 to 2014 in China;Hou;Kidney Dis (Basel),2018
2. Geographical distribution, a risk factor for the incidence of lupus nephritis in China;Pan;BMC Nephrol,2014
3. Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis;Cattran;Kidney Int,2012
4. American College of Rheumatology. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis;Hahn;Arthritis Care Res (Hoboken),2012
5. European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis;Bertsias;Ann Rheum Dis,2012
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Lupus Nephritis from Pathogenesis to New Therapies: An Update;International Journal of Molecular Sciences;2024-08-18
2. New guidelines and therapeutic updates for the management of lupus nephritis;Current Opinion in Nephrology & Hypertension;2024-02-09
3. Association Between Mycophenolate Mofetil Use and Subsequent Infections Among Hospitalized Patients with Systemic Lupus Erythematosus: A Nested Case–Control Study;Rheumatology and Therapy;2023-09-24
4. KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases;American Journal of Kidney Diseases;2023-08
5. Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian Population;American Journal of Kidney Diseases;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3